A randomized, double-blinded, placebo controlled phase III study to evaluate the immunogenicity and safety of GSK [GlaxoSmithKline] bio influenza vaccine (Fluarix) administered intramuscularly in healthy adults
Phase of Trial: Phase III
Latest Information Update: 24 Jan 2008
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 24 Jan 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
- 14 May 2007 New trial record.